Dapsone reduced cuprizone-induced demyelination via targeting Nrf2 and IKB in C57BL/6 mice

Document Type : Original Article

Authors

1 Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

2 Experimental Medicine Research Center, Tehran University of medical sciences, Tehran, Iran

3 Student Research Committee, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran

4 Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran

5 Medical Plant Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran

6 Department of Physiology and Pharmacology, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran

7 Animal Biology Department, Faculty of Biology, College of Sciences, University of Tehran, Tehran, Iran

8 Research Group on Community Nutrition and Oxidative Stress (NUCOX) and Health Research Institute of Balearic Islands (IdISBa), University of Balearic Islands, Palma de Mallorca E-07122, Balearic Islands, Spain

9 CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid

10 Instituto de Investigación y Postgrado, Facultad de Ciencias de la Salud, Universidad Central de Chile, Chile

11 Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, Spain

Abstract

Objective(s): Multiple Sclerosis (MS) is an inflammatory disorder wherein the myelin of nerve cells in the central nervous system is damaged. In the current study, we assessed the effect of Dapsone (DAP) on the improvement of behavioral dysfunction and preservation of myelin in the cuprizone (CPZ) induced demyelination model via targeting Nrf2 and IKB. 
Materials and Methods: MS was induced in C57BL/6 mice through diet supplementation of CPZ (0.2%) for 6 weeks, and DAP (12.5 mg/kg/day; IP) was administered for the last 2 weeks of treatment. Pole test and rotarod performance test, LFB and H&E staining, and Immunohistochemistry (IHC) staining of p-Nrf2 and p-IKB were performed. Furthermore, superoxide dismutase (SOD) and nitrite were measured.
Results: DAP treatment prevented body loss induced by CPZ (P<0.001). Pole test showed that CPZ increased latency time to fall (P<0.0001) but the latency to reach the floor in the DAP-CPZ group was significantly shorter (P<0.0001). Rotarod performance test showed the effect of CPZ in reducing fall time in the CPZ group (P<0.0014); however, DAP significantly increased fall time (P=0.0012). In LFB staining, DAP reduced demyelination induced by CPZ. CPZ significantly decreased p-Nrf2 and elevated p-IKB levels compared with the control group (P<0.0001), but in DAP-treated groups markedly modified these changes (P<0.0001). CPZ increased the brain nitrite levels and reduced SOD activity, but in DAP-treated considerably reversed CPZ-induced changes. 
Conclusion: These data support the suggestion that the beneficial properties of DAP on the CPZ-induced demyelination are mediated by targeting Nrf2 and NF-kB pathways.

Keywords

References

1. Noori T, Dehpour AR, Sureda A, Fakhri S, Sobarzo-Sanchez E, Farzaei MH, et al. The role of glycogen synthase kinase 3 beta in multiple sclerosis. Biomed Pharmacother 2020;132:110874.
2. Giovannoni G, Heales SJ, Silver NC, O’Riordan J, Miller RF, Land JM, et al. Raised serum nitrate and nitrite levels in patients with multiple sclerosis. J Neurol Sci 1997;145:77-81.
3. Butts BD, Houde C, Mehmet H. Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease. Cell Death  Differ 2008;15:1178-1186.
4. Mahurkar S, Suppiah V, O’Doherty C. Pharmacogenomics of interferon beta and glatiramer acetate response: a review of the literature. Autoimmun Rev 2014;13:178-186.
5. Praet J, Guglielmetti C, Berneman Z, Van der Linden A, Ponsaerts P. Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis. Neurosci Biobehav Rev 2014;47:485-505.
6. Carlton WW. Response of mice to the chelating agents sodium diethyldithiocarbamate, α-benzoinoxime, and biscyclohexanone oxaldihydrazone. Toxicol Appl Pharmacol 1966;8:512-521.
7. Abd El Aziz AE, Sayed RH, Sallam NA, El Sayed NS. Neuroprotective effects of telmisartan and nifedipine against cuprizone-induced demyelination and behavioral dysfunction in mice: Roles of NF-κB and Nrf2. Inflammation 2021; 44:1-14.
8. Carrete A, Padilla-Ferrer A, Simon A, Meffre D, Jafarian-Tehrani M. Effect of etazolate upon cuprizone-induced demyelination in vivo: Behavioral and myelin gene analysis. Neuroscience 2021;455:240-50.
9. Ding S, Guo Y, Chen X, Du S, Han Y, Yan Z, et al. Demyelination and remyelination detected in an alternative cuprizone mouse model of multiple sclerosis with 7.0 T multiparameter magnetic resonance imaging. Sci Rep 2021;11:1-11.
10. Jhelum P, Santos-Nogueira E, Teo W, Haumont A, Lenoël I, Stys PK, et al. Ferroptosis mediates cuprizone-induced loss of oligodendrocytes and demyelination. J Neurosci 2020;40:9327-9341.
11. Zhan J, Mann T, Joost S, Behrangi N, Frank M, Kipp M. The cuprizone model: dos and do nots. Cells 2020;9:843.
12. Messori L, Casini A, Gabbiani C, Sorace L, Muniz-Miranda M, Zatta P. Unravelling the chemical nature of copper cuprizone. Dalton Trans 2007; 21:2112-2114.
13. Acs P, Komoly S. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination. Ideggyogy Sz 2012;65:266-270.
14. Palumbo S, Toscano CD, Parente L, Weigert R, Bosetti F. The cyclooxygenase‐2 pathway via the PGE2 EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone‐induced demyelination. J Neurochem 2012;121:418-427.
15. Abd El Aziz AE, Sayed RH, Sallam NA, El Sayed NS. Neuroprotective effects of telmisartan and nifedipine against cuprizone-induced demyelination and behavioral dysfunction in mice: Roles of NF-κB and Nrf2. Inflammation 2021;44:1629-1642.
16. Khaledi E, Noori T, Mohammadi-Farani A, Sureda A, Dehpour AR, Yousefi-Manesh H, et al. Trifluoperazine reduces cuprizone-induced demyelination via targeting Nrf2 and IKB in mice. Eur J Pharmacol 2021;909:174432.
17. Zhang Q, Li Z, Wu S, Li X, Sang Y, Li J, et al. Myricetin alleviates cuprizone-induced behavioral dysfunction and demyelination in mice by Nrf2 pathway. Food Funct 2016;7:4332-4342.
18. Ahmed SMU, Luo L, Namani A, Wang XJ, Tang X. Nrf2 signaling pathway: Pivotal roles in inflammation. Biochim Biophys Acta Mol Basis Dis 2017;1863:585-597.
19. Saha S, Buttari B, Panieri E, Profumo E, Saso L. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules 2020;25:5474.
20. Sanadgol N, Barati M, Houshmand F, Hassani S, Clarner T, Golab F. Metformin accelerates myelin recovery and ameliorates behavioral deficits in the animal model of multiple sclerosis via adjustment of AMPK/Nrf2/mTOR signaling and maintenance of endogenous oligodendrogenesis during brain self-repairing period. Pharmacol Rep 2020;72:641-658.
21. Yousefi-Manesh H, Noori T, Asgardoon MH, Derakhshan MH, Tavangar SM, Sheibani M, Shirooie S, Dehpour AR. Protective effect of dapsone against bleomycin-induced lung fibrosis in rat. Exp Mol Pathol 2022;124:104737.
22. LA RD GA, Pannikar VK, t K JE, STIAN M. Clofazimine and dapsone compliance in leprosy. Published Quarterly for the British Leprosy Relief Association. 1988 Sep 1:205.
23. Hughes WT. Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: A review. Clin Infect Dis 1998;27:191-204.
24. Wozel G, Blasum C. Dapsone in dermatology and beyond. Arch Dermatol Res 2014;306:103-124.
25. Nezamoleslami S, Sheibani M, Jahanshahi F, Mumtaz F, Abbasi A, Dehpour AR. Protective effect of dapsone against renal ischemia-reperfusion injury in rat. Immunopharmacol Immunotoxicol 2020;42:272-279.
26. Sheibani M, Nezamoleslami S, Faghir-Ghanesefat H, Emami AH, Dehpour AR. Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats. Cancer Chemother Pharmacol 2020;85:563-571.
27. Diaz-Ruiz A, Roldan-Valadez E, Ortiz-Plata A, Mondragón-Lozano R, Heras-Romero Y, Mendez-Armenta M, et al. Dapsone improves functional deficit and diminishes brain damage evaluated by 3-Tesla magnetic resonance image after transient cerebral ischemia and reperfusion in rats. Brain Res 2016;1646:384-392.
28. Shirooie S, Khaledi E, Dehpour AR, Noori T, Khazaei M, Sadeghi F, et al. The effect of dapsone in testosterone enanthate-induced polycystic ovary syndrome in rat. J Steroid Biochem Mol Biol 2021;214:105977.
29. Rashidian A, Rashki A, Abdollahi A, Haddadi NS, Chamanara M, Mumtaz F, et al. Dapsone reduced acetic acid-induced inflammatory response in rat colon tissue through inhibition of NF-kB signaling pathway. Immunopharmacol Immunotoxicol 2019;41:607-613.
30. Mohamed A, Al-Kafaji G, Almahroos A, Almosawi Z, Alalwan H, Abdulla R, et al. Effects of enhanced environment and induced depression on cuprizone mouse model of demyelination. Exp Ther Med 2019;18:566-572.
31. Rashidian A, Rashki A, Abdollahi A, Haddadi N-S, Chamanara M, Mumtaz F, et al. Dapsone reduced acetic acid-induced inflammatory response in rat colon tissue through inhibition of NF-kB signaling pathway. Immunopharmacol Immunotoxicol 2019;41:607-613.
32. Dejban P, Rahimi N, Takzare N, Jahansouz M, Haddadi NS, Dehpour AR. Beneficial effects of dapsone on ischemia/reperfusion injury following torsion/detorsion in ipsilateral and contralateral testes in rat. Theriogenology 2019;140:136-142.
33. Mohammad Jafari R, Shayesteh S, Ala M, Yousefi-Manesh H, Rashidian A, Hashemian SM, et al. Dapsone ameliorates colitis through TLR4/NF-kB pathway in TNBS induced colitis model in rat. Arch Med Res 2021;52:595-602.
34. Margolis G, Pickett JP. New applications of the Luxol fast blue myelin stain. Laboratory investigation. J Tech Meth Pathol 1956;5:459-474.
35. Suetsugu H, Iimuro Y, Uehara T, Nishio T, Harada N, Yoshida M, et al. Nuclear factor {kappa}B inactivation in the rat liver ameliorates short term total warm ischaemia/reperfusion injury. Gut 2005;54:835-842.
36. Shirooie S, Sahebgharani M, Esmaeili J, Dehpour AR. In vitro evaluation of effects of metformin on morphine and methadone tolerance through mammalian target of rapamycin signaling pathway. J Cell Physiol 2019;234:3058-3066.
37. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170-3175.
38. Karin M. How NF-κB is activated: the role of the IκB kinase (IKK) complex. Oncogene 1999;18:6867-6874.
39. Prineas J. Pathology of inflammatory demyelinating neuropathies. Baillieres Clin Neurol 1994;3:1-24.
40. Lassmann H, Bradl M. Multiple sclerosis: experimental models and reality. Acta Neuropathol 2017;133:223-244.
41. McCarthy DP, Richards MH, Miller SD. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler’s virus-induced demyelinating disease. Methods Mol Biol 2012;900:381-401.
42. Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 2001;11:107-116.
43. Khaledi E, Noori T, Mohammadi-Farani A, Sureda A, Dehpour AR, Yousefi-Manesh H, et al. Trifluoperazine reduces cuprizone-induced demyelination via targeting Nrf2 and IKB in mice. Eur J Pharmacol 2021;909:174432.
44. Morell P, Barrett C, Mason J, Toews A, Hostettler J, Knapp G, et al. Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol Cell Neurosci 1998;12:220-227.
45. Vega-Riquer JM, Mendez-Victoriano G, Morales-Luckie RA, Gonzalez-Perez O. Five decades of cuprizone, an updated model to replicate demyelinating diseases. Curr Neuropharmacol 2019;17:129-141.
46. Abramovits W. Dapsone in Dermatology.  Biologic and Systemic Agents in Dermatology: Springer; 2018. p. 517-24.
47. Sheibani M, Nezamoleslami S, Faghir-Ghanesefat H, hossein Emami A, Dehpour AR. Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats. Cancer Chem Pharmacol 2020;85:563-571.
48. Yousefi-Manesh H, Noori T, Asgardoon MH, Derakhshan MH, Tavangar SM, Sheibani M, et al. Protective effect of dapsone against bleomycin-induced lung fibrosis in rat. Exp Mol Pathol 2022;124:104737.
49. Madanipour MR, Fatehi-zardalou M, Rahimi N, Hemmati S, Alaeddini M, Etemad-Moghadam S, et al. The anti-inflammatory effect of dapsone on ovalbumin-induced allergic rhinitis in balb/c mice. Life Sci 2022;297:120449.
50. Sheibani M, Nezamoleslami S, Rahimi N, Abbasi A, Dehpour AR. The protective effect of dapsone against ethanol-; stress-; and indomethacin-induced gastric erosion in rats. Acta Med Iran 2021;59:364-375.
51. Noroozi N, Shayan M, Maleki A, Eslami F, Rahimi N, Zakeri R, et al. Protective effects of dapsone on scopolamine-induced memory impairment in mice: Involvement of nitric oxide pathway. Demen Geriatr Cogn Dis Extra 2022;12:43-50.
52. Franco-Pons N, Torrente M, Colomina MT, Vilella E. Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination. Toxicol Lett 2007;169:205-213.
53. Elbaz EM, Senousy MA, El-Tanbouly DM, Sayed RH. Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: a pivotal role of AMPK/SIRT1 and JAK2/STAT3/NF-κB signalling pathway modulation. Toxicol Appl Pharmacol 2018;352:153-161.
54. Omotoso GO, Gbadamosi IT, Afolabi TT, Abdulwahab AB, Akinlolu AA. Ameliorative effects of Moringa on cuprizone-induced memory decline in rat model of multiple sclerosis. Anat Cell biol 2018;51:119.
55. Omotoso G, Olajide O, Gbadamosi I, Adebayo J, Enaibe B, Akinola O, et al. Cuprizone toxicity and Garcinia kola biflavonoid complex activity on hippocampal morphology and neurobehaviour. Heliyon 2019;5:e02102.
56. Dawson V, Brahmbhatt H, Mong J, Dawson T. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neuropharmacol 1994;33:1425-1430.
57. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature 1993;364:535-537.
58. Tobore TO. Oxidative/nitroxidative stress and multiple sclerosis. J Mol Neurosci 2021;71:506-514.
59. Ozdemir D, Uysal N, Gonenc S, Acikgoz O, Sonmez A, Topcu A, et al. Effect of melatonin on brain oxidative damage induced by traumatic brain injury in immature rats. Physiol Res 2005;54:631-637.
60. Omotoso GO, Ukwubile II, Arietarhire L, Sulaimon F, Gbadamosi IT. Kolaviron protects the brain in cuprizone-induced model of experimental multiple sclerosis via enhancement of intrinsic antioxidant mechanisms: Possible therapeutic applications? Pathophysiol 2018;25:299-306.
61. Faizi M, Salimi A, Seydi E, Naserzadeh P, Kouhnavard M, Rahimi A, et al. Toxicity of cuprizone a Cu2+ chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction. Toxicol Mech Methods 2016;26:276-283.
62. Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 2017;541:481-487.
63. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-318.
64. Vakilzadeh G, Khodagholi F, Ghadiri T, Ghaemi A, Noorbakhsh F, Sharifzadeh M, et al. The effect of melatonin on behavioral, molecular, and histopathological changes in cuprizone model of demyelination. Mol neurobiol 2016;53:4675-4684.
65. Labunets I, Rodnichenko A, Melnyk N, Utko N. Neuroprotective effect of melatonin in mice with toxic cuprizone model of demyelination and possible pathways of its realization. Cell and Organ Transplantology. 2018;6:145-151.
66. Mycko MP, Papoian R, Boschert U, Raine CS, Selmaj KW. cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity. Brain 2003;126:1048-1057.
67. Liu T, Zhang L, Joo D, Sun S-C. NF-κB signaling in inflammation. Signal Transduct Target Ther 2017;2:1-9.
68. Yamamoto Y, Gaynor RB. Role of the NF-kB pathway in the pathogenesis of human disease states. Curr Mol Med 2001;1:287-296.
69. Olugbemide AS, Ben-Azu B, Bakre AG, Ajayi AM, Femi-Akinlosotu O, Umukoro S. Naringenin improves depressive-and anxiety-like behaviors in mice exposed to repeated hypoxic stress through modulation of oxido-inflammatory mediators and NF-kB/BDNF expressions. Brain Research Bull 2021;169:214-227.
70. Zhang N, Jin L, Liu C, Zhang R, Siebert H-C, Li Y, et al. An antarctic krill oil-based diet elicits neuroprotective effects by inhibiting oxidative stress and rebalancing the M1/M2 microglia phenotype in a cuprizone model for demyelination. J Func Food 2021;76:104309.
71. Gopal S, Mikulskis A, Gold R, Fox RJ, Dawson KT, Amaravadi L. Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies. Mult Scler 2017;23:1875-1883.
72. Li W, Khor TO, Xu C, Shen G, Jeong W-S, Yu S, et al. Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis. Biochem Pharmacol 2008;76:1485-1489.
73. Hong Y, Yan W, Chen S, Sun C-r, Zhang J-m. The role of Nrf2 signaling in the regulation of antioxidants and detoxifying enzymes after traumatic brain injury in rats and mice. Acta Pharmacol Sin 2010;31:1421-1430.
74. Ríos C, Orozco-Suarez S, Salgado-Ceballos H, Mendez-Armenta M, Nava-Ruiz C, Santander I, et al. Anti-apoptotic effects of dapsone after spinal cord injury in rats. Neurochem Res 2015;40:1243-1251.
75. Diaz-Ruiz A, Salgado-Ceballos H, Montes S, Guizar-Sahagún G, Gelista-Herrera N, Mendez-Armenta M, et al. Delayed administration of dapsone protects from tissue damage and improves recovery after spinal cord injury. J Neurosci Res 2011;89:373-380. 
Iranian Journal of Basic Medical Sciences
Volume 25, Issue 6
June 2022
Pages 675-682

Files

Share

How to cite

Statistics